Fundamental Data for SHPGY

SHIRE PLC-(NSDQ:SHPGY)

Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)

# Employees: 3436

Address: Hampshire International Business Park Chineham,Basingstoke,Ha,

Phone: RG24 8EP

Fax: +44 1256 894-000

Website: investorrelations@uk.shire.com

Email: 44 1256 894 708

Sector: Medical

Industry: MED-DRUGS

Executive Officers

www.shire.com (James Cavanaugh Dr.)

Non-exec. Chmn. (Matthew Emmens)

C.E.O. (Angus Charles Russell)

C.F.O. (Tatjana May)

Exec. V.P. Global Legal Affairs; Genl. Counl.; Co. (Anita Graham Dr.,Exec. V.P. Corp. Buss. Services; Chief Admn. Off.,)

Dividend

Ex-Dividend Date: 9/9/2009

Annual Dividend: $0.30

Current Dividend Yield: $0.50

Dividend Paid (3 months): $0.06

Indicated Dividend: $0.09

Earnings

Last Earnings Date: 6/30/2009

Next Earnings Date(Expected): 2/18/2010

Mean EPS (Next Qtr): $0.58

Mean EPS (Year): $2.92

Mean Estimate(Long Term): $10.02

P/E Ratio(Based on EPS estimate): 20.200

Number of Estimates: 13

Shares Performance

Period	SHPGY	Compare to S&P
YTD	31.62 %	8.92 %
4 Weeks	10.58 %	4.98 %
12 Weeks	14.40 %	6.53 %

Shares Information

Analyst Coverage: Y

Avg Volume: 881221

Shares Outstanding: 186M

Market Cap: $11.01B

52 Week High: $59.80

52 Week Low: $32.02

P/E Ratio: 17.440

PEG Ratio: 2.020

Split: On 1/1/1990 SHPGY split by factor of 1.500

Earnings Performance

EPS Growth in Last Quarter: -18.33 %

EPS Growth in Last Year: -58.12 %

Sales Growth in Last Quarter: 5.87 %

Sales Growth in Last Quarter: -14.33 %

Financials

Qtr Book Value: $7.02

Cash Flow/Share: $12.12

Change in Payout Ratio: -0.010

Price/Sales: 3.820